(Alliance News) - Shield Therapeutics PLC, a Gateshead-based company specialising in iron deficiency medication, on Monday said it hired Hans-Peter Rudolf as its chief financial officer with immediate effect.
Starting in 2017, Rudolf was chief financial officer at Vicarius Pharma AG, which helped pharmaceutical companies sign license and partnership agreements. He previously had worked in the US and Switzerland for accountancies EY and Deloitte, in a career spanning 30 years.
Shield Chief Executive Tim Watts said: "I am delighted that Hans-Peter has agreed to join Shield at this point in the group's evolution. His experience in both public practice and commercial companies and his US experience will be invaluable to Shield, particularly as we scale up activities in the US."
Rudolf said: "I am honoured to join Shield's leadership team at this exciting moment and lead its finance organization to contribute to Shield's future success as the group progresses to the next phase of its strategy."
Shield shares were up 0.6% to 34.00 pence in London.
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Shield Thera (STX)